All Government articles – Page 59
-
NewsLitany of security breaches at US government science institute revealed
National Institute of Standards and Technology’s security lapses persist, more than two years after illegal meth production was uncovered at one of its sites
-
NewsUniversities to be assessed on business collaborations
Ref and Tef are set to be joined by Kef – the Knowledge Exchange Framework – in a new ranking to assess commercialisation of research
-
BusinessFederal court quashes Allergan eye drop patents
Ruling negates company’s deal with Mohawk tribe to avoid patent board review
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
-
NewsSuppression of academic freedom a ‘global crisis’
Universities around the world under attack as states and groups seek to silence free thought
-
NewsRoot and branch reform urged for Polish universities and research
EU report paints picture of out-of-date system
-
BusinessBASF to buy Bayer seeds and herbicides
€5.9bn sale will help satisfy competition regulators’ worries over Bayer–Monsanto merger
-
NewsCentral European University set to be saved as deadline passes
Hungarian university hopes international agreement will allow it to continue teaching
-
BusinessCall for overhaul of EU rules on GMO clinical trial
Rules designed around genetically modified plants crops are holding back new cell and gene-based medicines
-
NewsObama era clean power plan to be binned
US environment agency to end dalliance with country’s first limits on carbon emissions from coal-fired power plants
-
BusinessResidents sue Arkema over contamination
French chemical giant accused of releasing toxic chemicals from US plant in the wake of hurricane Harvey
-
NewsBan on the sale of acids to under-18s planned in UK
Home secretary announces measures to combat acid attacks
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
OpinionIndependent banking
Research shouldn’t be held ransom by the Spanish government in the fight over Catalonia
-
BusinessUS state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
NewsCatalan independence vote fallout sees research centres’ bank accounts frozen
Spanish government seized control of regional public finances prior to the referendum and may hold them indefinitely
-
NewsNorth Korean site identified as suspected rocket fuel facility
DPRK scientific publications reveal 1,1-dimethylhydrazine production
-
NewsHome Office blunder sees materials scientist told to 'leave the UK'
Electron microscopist’s case highlights the uncertain future facing European scientists in the UK
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessUS probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers